mpMRI scans can eliminate the need for prostate biopsy in 27 percent of men at risk

Another presentation at the ASCO annual meeting yesterday morning came from the PROMIS trial in the UK. The PROMIS trial was a prospective, paired-cohort confirmatory study, designed to provide level 1b evidence of the value of multi-parametric MRI (mpMRI) scanning as a test to see whether some men at hypothetical risk for prostate cancer could […]